Zobrazeno 1 - 10
of 18
pro vyhledávání: '"T S, Stroup"'
Autor:
Abraham M. Nussbaum, T S Stroup
Publikováno v:
The Cochrane Library
Background Paliperidone palmitate, a long-acting, intramuscular formulation of paliperidone, is now available for clinical use. Paliperidone is an active metabolite of risperidone and it is also available in an oral formulation for daily use. Objecti
Autor:
Karolina A. Aberg, E J C G van den Oord, Peilin Jia, Zhongming Zhao, Patrick F. Sullivan, Joseph L. McClay, Yunlong Liu, Daniel E. Adkins, T S Stroup, J A Lieberman, Diana O. Perkins, József Bukszár
Publikováno v:
The pharmacogenomics journal
QT prolongation is associated with increased risk of cardiac arrhythmias. Identifying the genetic variants that mediate antipsychotic-induced prolongation may help to minimize this risk, which might prevent the removal of efficacious drugs from the m
Autor:
Diana O. Perkins, Danyu Lin, Fei Zou, Jung-Ying Tzeng, A. M. Downing, Patrick F. Sullivan, E J C G van den Oord, T. S. Stroup, Seunggeun Lee, J A Lieberman, W. Liu, S. L. Close, Fred A. Wright, Michael J. Wagner
Publikováno v:
Molecular Psychiatry. 13:570-584
Little is known for certain about the genetics of schizophrenia. The advent of genomewide association has been widely anticipated as a promising means to identify reproducible DNA sequence variation associated with this important and debilitating dis
Publikováno v:
Hippocampus. 15:97-103
During aging, rats of both sexes experience a decline in performance on hippocampal-dependent tasks. Investigations into the neuroanatomical correlates of this functional decline have been conducted almost exclusively in male subjects. In the present
Publikováno v:
Schizophrenia Bulletin. 33:1274-1276
We found no difference for the outcome of unchanged or worse in the short term (n = 548, 2 randomized control trial (RCTs), RR = 1.00, 95% CI = 0.88 to 1.15). One study favored olanzapine for the outcome of relapse/rehospitalization by 12 months (n =
Publikováno v:
Dialogues in Clinical Neuroscience
Chlorpromazine, which was discovered in 1952, has an exhaustively characterized efficacy/safety profile comprising serious limitations: effectiveness in the field failing to match efficacy in trials, residual symptoms in 50% of patients, a 20% relaps
Autor:
T. S. Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Somaia Mohamed, Sonia M. Davis, Donald Addington, Robert A. Rosenheck, Marvin S. Swartz
Background According to the American Psychiatric Association Clinical Practice Guidelines for schizophrenia, second-generation antipsychotics may be specifically indicated for the treatment of depression in schizophrenia. We examined the impact of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf2f1e554160b028d60b493e73290b1
Autor:
József Bukszár, Peilin Jia, E J C G van den Oord, Patrick F. Sullivan, Daniel E. Adkins, Joseph P. McEvoy, Diana O. Perkins, T. S. Stroup, Zhongming Zhao, Karolina A. Aberg, Joseph L. McClay, Jeffrey A. Lieberman
Publikováno v:
Molecular psychiatry
Understanding individual differences in the susceptibility to metabolic side effects as a response to antipsychotic therapy is essential to optimize the treatment of schizophrenia. Here, we perform genomewide association studies (GWAS) to search for
Autor:
T S Stroup, Abraham M. Nussbaum
Publikováno v:
The Cochrane Library
Background Paliperidone, risperidone's active metabolite, is now available in an oral formulation for daily use, and an intramuscular formulation for monthly administration may follow shortly. Objectives To compare effects of oral paliperidone with a